Patents Assigned to Amrita Vishwa Vidyapeetham University
  • NANOPARTICLE FORMULATIONS FOR DELIVERING MULTIPLE THERAPEUTIC AGENTS
    Publication number: 20170119803
    Abstract: A formulation for treating a patient with hepatocellular carcinoma is disclosed. The formulation comprises therapeutic agents in the form of nanoparticles containing one or more proteins or polysaccharides. The therapeutic agent is conjugated to an active targeting agent causing the formulation to preferentially segregate to the hepatocellular carcinoma tissue to release the therapeutic agents. Methods of treating hepatocellular carcinoma using the formulations are also disclosed.
    Type: Application
    Filed: December 9, 2016
    Publication date: May 4, 2017
    Applicant: Amrita Vishwa Vidyapeetham University
    Inventors: MANZOOR KOYAKUTTY, GIRIDHARAN LOGHANATHAN MALARVIZHI, SHANTIKUMAR NAIR
  • Nanoparticle formulations for delivering multiple therapeutic agents
    Patent number: 9545382
    Abstract: A formulation for treating a patient with hepatocellular carcinoma is disclosed. The formulation comprises therapeutic agents in the form of nanoparticles containing one or more proteins or polysaccharides. The therapeutic agent is conjugated to an active targeting agent causing the formulation to preferentially segregate to the hepatocellular carcinoma tissue to release the therapeutic agents. Methods of treating hepatocellular carcinoma using the formulations are also disclosed.
    Type: Grant
    Filed: June 6, 2015
    Date of Patent: January 17, 2017
    Assignee: Amrita Vishwa Vidyapeetham University
    Inventors: Manzoor Koyakutty, Giridharan Loghanathan Malarvizhi, Shantikumar Nair
  • NANOPARTICLE FORMULATIONS FOR DELIVERING MULTIPLE THERAPEUTIC AGENTS
    Publication number: 20150342896
    Abstract: A formulation for treating a patient with hepatocellular carcinoma is disclosed. The formulation comprises therapeutic agents in the form of nanoparticles containing one or more proteins or polysaccharides. The therapeutic agent is conjugated to an active targeting agent causing the formulation to preferentially segregate to the hepatocellular carcinoma tissue to release the therapeutic agents. Methods of treating hepatocellular carcinoma using the formulations are also disclosed.
    Type: Application
    Filed: June 6, 2015
    Publication date: December 3, 2015
    Applicant: Amrita Vishwa Vidyapeetham University
    Inventors: MANZOOR KOYAKUTTY, GIRIDHARAN LOGHANATHAN MALARVIZHI, SHANTIKUMAR NAIR